drugset / Trial / NCT06226727
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this clinical study is to evaluate the pharmacokinetics and the safety after administration of "BR1019" and co-administration of "BR1019-1" and "BR1019-2" in healthy volunteers
Timeline
- Start
- 2024-02-14
- Primary completion
- 2024-03-31
- Completion
- 2024-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR1019 | Unknown | — | — |
| Subject | BR1019-1 | Unknown | — | — |
| Subject | BR1019-2 | Unknown | — | — |